Proteintech Triples its Size of Headquarters to Expand Operations and Meet Demand
Proteintech, the benchmark in antibodies, announces the tripling in size of its Rosemont, Illinois headquarters and laboratories to expand its antibody conjugation capabilities, increase GMP protein operations and add clinical capabilities to its antibodies’ portfolio, including IBVR and ASR.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210818005104/en/
Proteintech's new laboratory at its headquarters expands its operations and adds clinical capabilities. (Photo: Business Wire)
Proteintech’s move follows 20 years of strong and consistent growth at the company. Proteintech last expanded its headquarters just five years ago and expects to see growth continue amid demand for its antibodies, ELISA kits and protein products, according to Jeff Lee, Chief Operating Officer. In the past two years the company’s headcount has doubled to 300 employees and expects it to double again in two years.
“It’s a big year for Proteintech with it being our 20th year in business, receiving our 100,000th citation of our products in scientific publications, and expanding but we wouldn’t have this company or any of its successes without our people,” said CEO Dr. Jason Li. “Every step our employees took have made this company what it is today. They have made our company strong.”
“The 100,000 citations we’ve received over the years is a contributing factor to our expansion. The consistent growth of citations from researchers using our products is a direct reflection on the value that researchers place on the consistent quality and reproducibility of our products correlating with the growth we’ve seen,” said Dr. Deepa Shankar, Chief Scientific Officer.
The new headquarters will also house expanding operations for Proteintech’s North American distribution, R&D, finance, logistics, customer support, and IT.
About Proteintech Group
Proteintech, founded in 2001, is a leading manufacturer of antibodies, proteins and immunoassays. Proteintech has the largest proprietary portfolio of self-manufactured antibodies covering 2/3 of the human proteome. In addition, Proteintech produces cytokines, growth factors and other proteins that are human expressed, bioactive and cGMP-grade. With the recent acquisition of manufacturer ChromoTek, Proteintech now offers nanobodies, high-performance recombinant reagents used in single cell analysis, super resolution imaging, and multiplex assays. Proteintech sites are ISO13485 and ISO9001-2015 accredited. To learn more about Proteintech, please visit www.ptglab.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
Thompson + Conard Communications
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Ibsen Scope Is Announcing Grants 202228.9.2021 13:00:00 EEST | Press release
Ibsen Scope Grants 2022 are now applicable for individual artists, theatre companies, institutions and organizations worldwide. The program amount to a total of NOK 2.000.000,-. (Approx. Euro 205.000,- /USD 248.000,-). The program offers funding for innovative performing arts projects. The projects must act as incentives for critical discourses on society related matters and be based on one or more of Henrik Ibsen’s plays. Applications are submitted through our website, and an appointed jury will evaluate the applications. For further information, statutes and application form see www.ibsenscope.com Deadline for applications is December 9th 2021. The winners of the Ibsen Scope Grants 2022 will be invited to Ibsen Scope Festival at Teater Ibsen in Skien, Norway in May 2022. Not heard of Ibsen Scope? We have changed our name. Ibsen Awards is now Ibsen Scope! We still look at the world through Henrik Ibsen’s lenses. We still engage in vivid, critical and artistic discourses on the works a
REPLY: Countdown to the Reply Cyber Security Challenge 202128.9.2021 10:30:00 EEST | Press release
On the 15th of October 2021, Reply will launch the fourth edition of the Reply Cyber Security Challenge, a team-based coding competition open to young professionals and cyber security enthusiasts from all over the world. This year’s edition will be supported by Intesa Sanpaolo, one of the top banking groups in Europe, and Immersive Labs, the platform empowering businesses to increase, measure and evidence human capability in every part of their cybersecurity. Intesa Sanpaolo‘s support confirms its commitment to increase education, awareness and training on cybersecurity among young people. Improving cybersecurity knowledge, skills and judgement is Immersive Labs’ mission and the Reply Cyber Security Challenge represents a new and engaging way to power up people’s cyber capabilities. The challenge, which in 2020 welcomed more than 10,000 participants from 160 countries gather together in 2,380 teams, aims to put teams (from 2 to 4 players) in competition in a 24-hour marathon, Capture T
Speech Processing Solutions (SPS) becomes a Nuance Dragon Medical One Distributor in Europe and Asia Pacific Region28.9.2021 10:02:00 EEST | Press release
Speech Processing Solutions (SPS), a leader in professional dictation, has announced they are joining forces with Nuance Communications as an official distributor of Nuance Dragon Medical One, the leading cloud-based speech recognition solution for clinical documentation, in Europe and Asia Pacific Regions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210928005069/en/ © Philips Dictation (Photo: Business Wire) One-stop shop for all voice-to-text needs This agreement enables SPS to become a one-stop-shop for healthcare solution partners and resellers providing dictation, speech recognition, and transcription software, as well as all hardware needs. The Nuance Dragon Medical One solution, which allows clinicians to document the complete patient record by voice, can now be easily combined with leading dictation workflow software and dictation hardware, such as the leading Philips SpeechMike line-up. Dr. Thomas Brauner, CEO of
Tigo Energy to Reveal New Solutions for Solar Fleet Management and Fire Safety at Intersolar Europe28.9.2021 10:00:00 EEST | Press release
Tigo Energy, Inc., the solar industry’s worldwide leader in Flex MLPE (Module Level Power Electronics), confirms the Company’s presence at the upcoming Intersolar Europe in Munich, Germany. Tigo representatives will showcase the entire family of Tigo TS4 Flex MLPE devices, including the recently introduced TS4-A-2F and the Tigo Energy Intelligence software platform. Together, these Tigo products make up the most cost-effective and advanced solution for rapid shutdown on large-scale solar projects. Tigo Energy has led solar innovation with its Tigo TS4 Flex MLPE by providing the freedom for customers to choose the features and components for their solar installations. Over the past 12 months, Tigo released key updates and innovations to its Flex MLPE product line to address the growing demand for high-power solar modules and energy projects that call for a diversified set of fire safety, monitoring, management, and power optimization features. “The Tigo TS4 is a fixture in the systems w
Galderma to Unveil Ground-breaking Data From Across Its Leading Dermatology Portfolio and Showcase Major Update for Sensitive Skincare Brand CETAPHIL® at the 2021 EADV Congress28.9.2021 09:30:00 EEST | Press release
Galderma’s presence at the 2021 European Academy of Dermatology and Venereology (EADV) virtual congress on September 29 – October 2 will reveal new data and showcase the company’s sophisticated portfolio and services across the spectrum of dermatology. The company’s redesigned virtual booth will have dedicated areas presenting Galderma’s innovations in Consumer Care and Prescription Medicine. Unveiling new data in Prescription Medicine The congress will see the unveiling of exciting new data from Galderma relating to rosacea, acne, actinic keratosis, atopic dermatitis and prurigo nodularis. Attendees will have the opportunity to ask questions to the faculties during live Q&A sessions. On Thursday, September 30, Professor Alison Layton^ will chair the symposium Personalizing Acne: Consensus of Experts to Optimize Acne Management. Together with her co-speakers, Professor Layton will provide practical solutions for longitudinal management of acne. On the same day, Professor Gil Yosipovitc
ThreatConnect Expands Into South Africa, Partnering With Leading MSSP28.9.2021 08:00:00 EEST | Press release
ThreatConnect, Inc.®, the leader in reducing complexity and enabling better decision-making in cybersecurity, announced that it has entered a strategic partnership with BUI, Microsoft’s largest Security and Consulting Partner in South Africa. BUI is an award-winning Microsoft Azure Expert MSP, a member of the Microsoft Intelligent Security Association, and a Gold Microsoft Partner delivering cloud and security solutions, as well as professional services, in SA and across the world. With Cyber Risk Quantification (CRQ), Threat Intelligence Platform (TIP) and Security Orchestration, Automation, and Response (SOAR) capabilities combined, ThreatConnect unifies the actions of the security team around the most critical tasks, supports their response with streamlined and automated workflows, and strengthens the entire security ecosystem through powerful technology integrations. With ThreatConnect’s comprehensive intelligence-driven SOAR, BUI (among other MSSPs) sees a plethora of immediate be
GlobalLogic Launches Collaborative Hub Based in Lumada Innovation Hub Tokyo28.9.2021 03:00:00 EEST | Press release
Hitachi, Ltd. (TSE: 6501, “Hitachi”) and GlobalLogic*1, a Hitachi Group Company, today announced the launch of a collaborative hub to promote digital transformation (DX) services in the Japanese market. Based in the Lumada Innovation Hub Tokyo*2, a co-creation base for Hitachi, this collaboration hub combines capabilities of GlobalLogic and Lumada. Delivering on the joint integration strategy, this partnership aims to jump-start GlobalLogic’s entry into Japan, and will accelerate business development for design-led Digital Engineering services of GlobalLogic, establishing a system to support customers in Japan starting from fiscal 2022. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210927005848/en/ A workshop connecting “Lumada Innovation Hub Tokyo” and GlobalLogic's Design and Engineering Centers. (Photo: Business Wire) "The market demand for DX continues to grow at a fast pace, as global brands increasingly leverage digit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom